Foam treatment for eczema in children and infants
Part of Genetic & congenital, Immune system & allergy, Skin clinical trials.
This trial tests a new foam medicine for children and infants with mild-to-moderate eczema (atopic dermatitis). The foam is applied to the skin to help reduce symptoms and improve the condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have atopic dermatitis (eczema) diagnosed by a doctor.
- The eczema must cover between 5% and 40% of the body (excluding the scalp). That's roughly a few handprints to about half an arm or back.
- The overall severity should be mild or moderate (not clear, not severe).
- No severe flare-up or contact dermatitis in the past 28 days.
- Your child must not have used this study medicine before.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new foam medication for adults with atopic dermatitis (a type of eczema). It aims to see if the foam is better than a placebo (a foam with no active ingredient) at treating the condition.
This study tests a new cream called JYP0066 for people with mild-to-moderate atopic dermatitis (eczema). It aims to see if the cream safely reduces itching and skin inflammation. It might help if you have tried other creams and still have symptoms.
This trial tests whether a special herbal ointment can help treat atopic dermatitis (eczema). It is for adults with mild, moderate, or severe eczema covering less than 10% of their body surface. The ointment is applied directly to the skin, and participants will also use a gentle, fragrance-free moisturizer.
This trial tests a study drug (PF-08049820) for people with moderate to severe eczema who haven't found a suitable prescription treatment. It aims to see if the drug can improve skin symptoms and itching.
This trial tests a new gel called PG-011 for people with mild to moderate eczema (atopic dermatitis). The gel is applied to the skin, and the study will check if it helps improve symptoms safely.
This study tests a new ointment called IN-115314 for adults with mild to moderate eczema. Researchers want to see if it helps control symptoms like itching and redness better than a placebo, and check that it's safe to use.
Hear when a new Atopic Dermatitis (AD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.